ArticleBMC public health2025
Stakeholders' perspectives on lessons learnt from HPV mass vaccination in Nigeria.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Article
- HPV knowledge and willingness to receive HPV vaccine among female secondary school students in Ebonyi State, Nigeria: a pre-post evaluation of an educational intervention.BMC public health · 2026Article
- HPV vaccination policies and implementation for adolescents in low- and middle-income countries: a scoping review.The Lancet regional health. Western Pacific · 2026Review
- HPV vaccine awareness, perceptions, uptake, and school-based information channels during Nigeria's national rollout: a cross-sectional study among adolescent girls in rural Oyo State.BMC public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo effectively reduce the risk of cervical cancer, Nigeria launched the HPV vaccine introduction using a phased approach; first phase in October 2023 across 16 states and the second phase across 21 states in May 2024. This initiative aimed to protect girls aged 9-14 from HPV infections, a primary cause of cervical cancer, through strategic planning and targeted implementation. This paper aims to share the Stakeholders' perspectives from nine states in Nigeria on lessons learnt during HPV vaccination that could be adopted in future campaigns and vaccinations.
methodsThe study adopted a qualitative research design to evaluate the strategies deployed, challenges encountered, and lessons learned from the HPV Phase II vaccination campaign. Key informant interviews and in-depth interviews were conducted with officers of the healthcare agencies at the national, state, local government and ward levels and representatives of CSOs, who had key information about the strategies and those who implemented policies during the HPV mass vaccination in nine states in Nigeria. The qualitative data was validated, transcribed, coded and analyzed thematically.
resultsKey components of the campaign included the establishment of fixed and temporary vaccination posts, strategic school and community engagement, and targeted communication efforts via social media, influencers, and local leaders. Cultural sensitivity, trained health workers, and data-driven micro plans were emphasized to enhance the program's effectiveness. The campaign successfully raised awareness and increased vaccination coverage across the nine targeted states. Effective strategies included leveraging cultural sensitivity, utilizing trained health workers, and employing data-driven micro plans to address logistical challenges. Despite these successes, significant challenges were encountered. Vaccine hesitancy fueled by misinformation about sterility, limited resources, security concerns, and difficulties accessing remote areas posed barriers to achieving wider coverage. Key lessons from the campaign highlighted the importance of early planning, effective rumor management through existing networks, and the crucial role of influential community members in amplifying the message and encouraging participation.
conclusionThe findings highlight critical lessons for future vaccination programs. Early planning, proactive social mobilization, effective rumor management, and leveraging community networks were instrumental in enhancing vaccine acceptance and coverage. These strategies serve as a model for overcoming barriers to public health interventions and should be prioritized in future efforts to improve HPV and other vaccination programs in Nigeria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.